Hipertensi Esensial
Hipertensi Esensial
Hipertensi Esensial
ESENSIAL
FAKULTAS KEDOKTERAN
UNIVERSITAS MALAHAYATI
2011
DEFENISI
TDS (mmHg)
TDD (mmHg)
< 120
< 80
Prahipertensi
120 139
80 89
Hipertensi derajat
1
140 159
90 99
Hipertensi derajat
2
160
100
Normal
Classification of Blood
Pressure
ESC-ESH 2007
JNC-VII
Optimal
: <120 and < 80
Normal
: 120-129 and/or 80 - 84
High Normal : 130-139 and/or 85-89
Grade 1 : 140-159 and/or 90-99
Grade 2 : 160-179 and/or 100-109
Grade 3 : > 180 and/or > 110
Normal
Pre-hypertension
Stage 1
Stage 2
H
Y
P
E
R
T
E
N
S
IO
N
Epidemiology of
Hypertension
American Heart Association Heart Disease and Stroke statistic 2006 Update, Texas, AHA2006
American Heart Association Heart Disease and Stroke statistic 2006 Update, Texas, AHA2006
The Cardiovascular
Continuum
Myocardial
infarction
Coronary
thrombosis
Sudden Death
Arrhythmia &
loss of muscle
Myocardial
ischaemia
CAD
Atherosclerosis
LVH
Risk factors
Remodelling
Ventricular
dilatation
Congestive
heart failure
Death
PATOGENESIS
Faktor yang mendorong terjadinya hipertensi :
1. Diet & asupan garam, stress, ras, obesitas,
merokok, genetis
2. Sistem saraf simpatis :
- Tonus simpatis
- Variasi diurnal
3. Keseimbangan antara modulator vasodilatasi &
vasokonstriksi
4. Pengaruh sistem endokrin setempat yang
berperan pada sistem renin, angiotensin &
aldosteron
Consequences Structural
Changes in Hypertension
Loss of buffering
Function
Transmits
Systolic pressure
Wave to small arteries
Compliance
Shear stress on
Artery wall
Endothelial
dysfunction
Load on heart
Perpetuation of
Hypertension
Left Ventricular
Hypertrophy
Predisposes of
Atherosclerosis
Dzau VJ. Hypertension. 2001;37:1047-1052
Diastolic
dysfunction
CHF
Hypertension
MI
Death
Systolic
dysfunction
LV
Subclinical
Overt
Normal LV
Structure & Functionremodeling LV dysfunction Heart Failure
Time
(decades)
Time
(months)
Stage 2 hypertension
15
CHF
Cumulative
Incidence 10
(%)
Stage 1 hypertension
5
Normal BP
5
10
Years From Baseline Exam
15
2.
3.
4.
5.
Jantung :
- Hipertrofi ventrikel kiri
- Angina atau infark miokardium
- Gagal jantung
Otak :
- Stroke atau Transient ischemic attack
Penyakit ginjal kronis
Penyakit arteri perifer
Retinopati
EVALUASI HIPERTENSI
Tujuan :
1.Menilai pola hidup & identifikasi faktor-faktor
resiko kardiovaskular lainnya
2.Mencari penyebab kenaikan tekanan darah
3.Menentukan ada atau tidaknya kerusakan
target organ & penyakit kardiovaskular
Aterosklerosis
Diabetes
Penyakit ginjal
PENGOBATAN
Tujuan pengobatan :
2. Terapi farmakologis
Jenis-jenis obat yang dianjurkan :
Diuretika
Beta blocker
Calsium Channel Blocker atau Calcium antagonist
Angiotensin Converting Enzyme Inhibitor
Angiotensin II Receptor AT1 receptor
antagonist/blocker (ARB)
* Tunggal atau kombinasi
Possible Combinations of
Antihypertensive Agents
Diuretics
Angiotensinreceptor blockers
Beta-blockers
Diltiiazem
Alpha-blockers
Calcium
channel blockers
ACE inhibitors
Guidelines Committee. J Hypertens 2003; 21:
21: 1011-53.
LIFESTYLE MODIFICATIONS
Not Goal BP
Stage 1
Stage 2
Thiazide-Type
diuretics for most.
May consider ACEI,
ARB, BB, CCB, or
combination
Two Drug
combination for most
(usually thiazide-type
diuretic and ACEI, or
ARB, or BB, or CCB
BB, CCB) as
needed
Renal Protection
Strict BP Control
Target BP:
<130/85 mm Hg
130/80 (ADA guidelines)
<125/75 mm Hg
(if proteinuria > 1g/24h)
Control of Proteinuria
Ideally = 0 mg/24h Mikroalbumiuri (0-300mg/24h)
American Diabetes Association. Diabetes Care. 2002;25 (Suppl.1):S85-S89.